Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
Conditions
Interventions
Control Intervention1: Nil: Nil
Sponsors
Dr Saavi Sharma
Eligibility
Inclusion criteria
Inclusion criteria: All patients above 18 years with Gastric Carcinoma who underwent curative total or subtotal gastrectomy with D1 or D2 lymph node dissection
Exclusion criteria
Exclusion criteria: Any patient with 1.Incomplete postoperative pathology reports 2.Patients with less than 15 nodes cleared 3. Patients treated with neoadjuvant chemotherapy or radiotherapy. 4. Patients with concurrent malignancies 5. Patients with hematological disorders Incomplete data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Predictive value of HALP score on lymphnode Metastasis in operable gastric cancer 2. Develop a nomogram for more accurate assessment of lymph node metastasis in Gastric carcinoma patients.Timepoint: 12 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Determinethe predictive accuracy of neutrophil lymphocyte ratio, platelet lymphocyte ratio , prognostic nutritional index , systemic immune inflammation index , systemic inflammation and respiration index individually for Lymph Node Metastasis in Gastric carcinoma patients 2. To assessment the association of HALP score , NLR, PLR, PNI , SII,SIRI with patients and tumor characteristics like age, sex , ECOG status comorbidities , tu or pathology, tumor differentiation and location.Timepoint: 12 years | — |
Countries
India
Contacts
Public ContactDr Anandhi Ramesh
JIPMER
Outcome results
None listed